Psoriatic Arthritis and Regenerative Medicine: Exploring the Therapeutic Potential of Umbilical Cord–Derived Mesenchymal Stem Cells
Treatments By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality Every treatment uses the same Passage 3 protocol. View all treatments How it works Your journey Testimonials Pricing About The center The company The stem cells Facilities People & place Dr. Diana Reyes The team About Medellín ENES Book your consultation Message us Treatments + By body area Knee & joints Spine, neck & back Hip Shoulder By condition Autoimmune & inflammatory Neurological Diabetes Anti-aging & vitality View all treatments → How it works Your journey Testimonials Pricing About + The company The stem cells Dr. Diana Reyes The team Facilities About Medellín ENES Book your consultation Message us on WhatsApp Regenerative science Psoriatic Arthritis and Regenerative Medicine: Exploring the Therapeutic Potential of Umbilical Cord–Derived Mesenchymal Stem Cells Psoriatic arthritis (PsA) is a chronic, immune-mediated inflammatory disease associated with psoriasis that affects both peripheral joints and axial… By Dr. Diana ReyesFebruary 2026 Psoriatic arthritis (PsA) is a chronic, immune-mediated inflammatory disease associated with psoriasis that affects both peripheral joints and axial structures. The condition is heterogeneous in presentation, often involving synovitis, enthesitis, dactylitis, and progressive joint destruction. Beyond musculoskeletal involvement, psoriatic arthritis is recognized as a systemic inflammatory disorder with metabolic, cardiovascular, and dermatologic implications. Although conventional therapies—including nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologic agents—can reduce symptoms and slow disease progression, a significant subset of patients experience inadequate responses, intolerance, or loss of efficacy over time. These limitations have prompted interest in regenerative medicine approaches, particularly those utilizing umbilical cord–derived mesenchymal stem cells (UC-MSCs), which target immune dysregulation at a biological level. Immunopathology of Psoriatic Arthritis Psoriatic arthritis arises from a complex interaction between genetic predisposition, environmental triggers, and immune system dysfunction. Unlike purely mechanical joint disorders, PsA is driven by chronic immune activation affecting both skin and musculoskeletal tissues. Key pathological mechanisms include: According to Ritchlin et al. (2017), psoriatic arthritis represents a systemic inflammatory disease in which immune-mediated pathways drive joint damage and extra-articular manifestations. Rationale for Umbilical Cord–Derived Mesenchymal Stem Cells Umbilical cord–derived MSCs, commonly isolated from Wharton’s jelly, possess unique biological properties that make them particularly suitable for immune-mediated inflammatory diseases such as PsA. UC-MSCs demonstrate: Compared with adult-derived MSCs, UC-MSCs exhibit enhanced proliferative capacity and stronger paracrine signaling, which is critical for systemic immune regulation. Mechanisms of Action in Psoriatic Arthritis The therapeutic effects of UC-MSCs are primarily mediated through immune modulation rather than direct tissue replacement. Proposed mechanisms include: Galipeau and Sensébé (2018) emphasize that MSCs act as dynamic immune regulators capable of restoring immune balance in chronic inflammatory diseases. Emerging Clinical and Translational Evidence UC-MSC Therapy in Immune-Mediated Arthritis Preclinical and early clinical studies suggest that MSC therapy can significantly reduce inflammatory activity in immune-mediated arthritides, including psoriatic arthritis. In experimental models, MSC administration has been shown to reduce joint inflammation, suppress pathogenic cytokines, and improve functional outcomes. Systemic Benefits Beyond the Joint Because psoriatic arthritis is a systemic disease, the ability of UC-MSCs to modulate immune activity at a systemic level is particularly relevant. This includes potential benefits for skin inflammation, fatigue, and other extra-articular symptoms commonly associated with PsA. Evidence from Reviews and Mechanistic Studies Immune Modulation“Mesenchymal stromal cells exert broad immunosuppressive effects and can inhibit pathogenic T-cell responses in inflammatory arthritis.”— Galipeau & Sensébé, 2018 Cytokine Regulation“Targeting the IL-17 and IL-23 pathways is central to controlling psoriatic arthritis–related inflammation.”— Veale & Fearon, 2018 Safety“Clinical use of allogeneic MSCs has consistently demonstrated a favorable safety profile across immune-mediated conditions.”— Squillaro et al., 2016 Conclusion Psoriatic arthritis is a complex systemic inflammatory disease driven by persistent immune dysregulation and progressive joint damage. Umbilical cord–derived mesenchymal stem cells offer a regenerative and immunomodulatory approach that addresses the biological mechanisms underlying disease activity. Current evidence suggests that UC-MSC–based therapies may provide: As research advances, UC-MSC therapy represents a promising adjunctive strategy for patients with psoriatic arthritis who seek biologically targeted, non-surgical treatment options. References (APA 7th Edition – New Sources, Functional Links) Talk to our medical team ← Keep reading Welcome to Medellín Your treatment can start this week. No months-long waitlist. Message us and a real person — Mía — will get back to you in minutes. Message us on WhatsApp Book your consultation A leading center in regenerative medicine, dedicated to pain relief and health you can feel. Explore Treatments How it works Testimonials Pricing Blog FAQs Book Company About Dr. Diana Reyes The team Facilities About Medellín Contact WhatsApp +57 310 881 9333 info@stemcellscolombia.com Incodol Sede Balsos, Carrera 25 #9A Sur-162, Consultorio #3, El Poblado, Medellín Mon–Fri 10am–6pm · Sat 10am–2pm (GMT-5) Medical disclaimer. Stem cell therapy does not guarantee results and is not marketed as a definitive cure. A comprehensive review of each patient’s medical history is required to assess eligibility. Individual results vary; these therapies are not approved by the FDA and are not a substitute for conventional medical care. Any personal information shared is used solely within our medical team. © 2026 Stemcells Colombia. All rights reserved. Terms Privacy SMS Policy Chat with us